Touchstone
Last syncNov 1, 2026, 6:55 PM ET

PBH

Prestige Consumer Healthcare Inc. Health Care Pharmaceutical Preparations Russell 3000
$49.06Close $2.8BMarket cap $44.77 – $70.2152-week range Nov 5, 2026Next report · before the open

Highlights

Cautions

  • Not in an uptrend 1 of 8 trend conditions
  • Lagging the market RS 23 · weaker than 77% of stocks over 12 months
  • Far from its high 30% below its 52-week high
  • Earnings shrinking EPS −36% year on year
  • Results soon Nov 5, 2026, in 4 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Mar 31, 2026 · filed Aug 6, 2026
Off 12-month high 30%
1wk up 2.6% price change
1mo up 7.0% price change
12-month return down 19% market up 11% · its own down 30%
F-score 4 / 9 Weak
Altman Z 2.44 Moderate risk
P/E 14.5× price / earnings
PEG — P/E / EPS growth
P/B 1.5× price / book
Earnings yield up 8.4% EBIT / enterprise value
Cheaper than 85% of the market · markedly cheap
Revenue growth down 4% year on year
EPS growth down 36% latest quarter · -49 pts
Sales growth up 6% latest quarter · +12 pts
ROE up 10% return on equity
Free cash margin up 23% $246.4M FCF
D/E 0.53 long-term debt / equity
Net debt / EBITDA 2.7×
Interest cover 7.3×EBIT / interest
Piotroski tests
  • profitability slipped from last year
  • short-term liquidity weakened
  • issued more shares
  • gross margin narrowed
  • assets working less efficiently
  • profitable on its assets
  • generating cash from operations
  • profits backed by cash
  • reduced long-term debt

Trade setup

ATR% 3.0% $1.48 a day · 2×ATR $46.11
RS 23 / 99 vs the universe
Trend 1 / 8 trend template
Relative volume 0.7× vs 50-day average
Up/down volume 0.95 50 sessions
Implied move — no option chain · report Nov 5, 2026
Trend template · 1 of 8
  • Price above the 50-day average: passes

Screen verdict

Did not qualify for any screen.

Warning signs

2 flagged
  • Gross margin narrowing Gross margin fell from 55.8% to 54.7%. The company is keeping less of each dollar of sales than it did a year ago.
  • Revenue shrinking Revenue fell 4.3% over the year, from $1.1B to $1.1B.
Last reported Aug 6, 2026
Results reaction Aug 6, 2026+3% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $1.1B -4% on FY2025
$0 $2B FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · $943.4M FY2022 · $1.1B FY2023 · $1.1B FY2024 · $1.1B FY2025 · $1.1B FY2026 · $1.1B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $190.3M -11% on FY2025
-$100M $0 $250M FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · $164.7M FY2022 · $205.4M FY2023 · -$82.3M FY2024 · $209.3M FY2025 · $214.6M FY2026 · $190.3M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $246.4M +1% on FY2025
$0 $500M FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · $213.4M FY2022 · $250.3M FY2023 · $221.9M FY2024 · $239.4M FY2025 · $243.3M FY2026 · $246.4M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 55%
  • Net 17%
  • Free cash 23%
0% 100% FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · Gross 58% · Net 17% · Free cash 23% FY2022 · Gross 57% · Net 19% · Free cash 23% FY2023 · Gross 55% · Net -7% · Free cash 20% FY2024 · Gross 55% · Net 19% · Free cash 21% FY2025 · Gross 56% · Net 19% · Free cash 21% FY2026 · Gross 55% · Net 17% · Free cash 23%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $930.1M net debt
  • Cash
  • Long-term debt
$0 $2B FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · Cash $32.3M · Long-term debt $1.5B FY2022 · Cash $27.2M · Long-term debt $1.5B FY2023 · Cash $58.5M · Long-term debt $1.3B FY2024 · Cash $46.5M · Long-term debt $1.1B FY2025 · Cash $97.9M · Long-term debt $992.4M FY2026 · Cash $63.9M · Long-term debt $994.0M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 56.21m +4.1% since FY2021
56.21m 54m FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · 54m FY2022 · 54.43m FY2023 · 54.86m FY2024 · 55.50m FY2025 · 56.01m FY2026 · 56.21m
  FY2021Mar 31, 2021 FY2022Mar 31, 2022 FY2023Mar 31, 2023 FY2024Mar 31, 2024 FY2025Mar 31, 2025 FY2026Mar 31, 2026
Revenue $943.4M $1.1B $1.1B $1.1B $1.1B $1.1B
Gross margin 58% 57% 55% 55% 56% 55%
Operating income $297.4M $329.9M -$22.4M $342.4M $336.8M $309.4M
Net income $164.7M $205.4M -$82.3M $209.3M $214.6M $190.3M
Net margin 17% 19% -7% 19% 19% 17%
Earnings per share $3.25 $4.04 -$1.65 $4.17 $4.29 $3.91
Free cash flow $213.4M $250.3M $221.9M $239.4M $243.3M $246.4M
Free cash margin 23% 23% 20% 21% 21% 23%
Cash $32.3M $27.2M $58.5M $46.5M $97.9M $63.9M
Long-term debt $1.5B $1.5B $1.3B $1.1B $992.4M $994.0M
Shareholders' equity $1.4B $1.6B $1.4B $1.7B $1.8B $1.9B
Shares outstanding 54m 54.43m 54.86m 55.50m 56.01m 56.21m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 6, 2026 Quarterly ↗ Jun 30, 2026 37d
May 14, 2026 Annual ↗ Mar 31, 2026 44d
Feb 5, 2026 Quarterly ↗ Dec 31, 2025 36d
Nov 6, 2025 Quarterly ↗ Sep 30, 2025 37d
Aug 7, 2025 Quarterly ↗ Jun 30, 2025 38d
May 9, 2025 Annual ↗ Mar 31, 2025 39d
Feb 6, 2025 Quarterly ↗ Dec 31, 2024 37d
Nov 7, 2024 Quarterly ↗ Sep 30, 2024 38d
Aug 8, 2024 Quarterly ↗ Jun 30, 2024 39d
May 15, 2024 Annual ↗ Mar 31, 2024 45d
Feb 8, 2024 Quarterly ↗ Dec 31, 2023 39d
Nov 2, 2023 Quarterly ↗ Sep 30, 2023 33d

Current reports

FiledDisclosed
Aug 14, 2026 Director or officer change ↗
Aug 6, 2026 Results · Regulation FD ↗
Jul 15, 2026 Material agreement · New obligation ↗
Jul 6, 2026 Material agreement · New obligation · Regulation FD ↗
Jun 16, 2026 Material agreement · Acquisition or disposal · New obligation · Other events ↗
May 13, 2026 Material agreement · Results · Regulation FD ↗
Mar 20, 2026 Material agreement · Regulation FD · Other events ↗
Feb 5, 2026 Results · Regulation FD ↗
Nov 6, 2025 Results · Regulation FD ↗
Aug 7, 2025 Material agreement · Results · Regulation FD ↗
May 8, 2025 Results · Regulation FD ↗
Feb 6, 2025 Results · Regulation FD ↗